Member Info for Laura2022

Business owner

Trout has spent most of his time on PYC last 7 weeks bizarre...and silent on HVO which is tanking

Trout

You're wanted on HVO and FAB boards where you've gone silent

Takeover or increased share buy backs

Looking good

Moving now

404x

The most vulnerable have shocking 5yr corporate history and full of insiders owning 40-60% who can wash their hands of failure

Ceo and insiders own 40%

These changes at the Board level form part of implementing a significant restructure and reduction in headcount across the Company As part of the restructure, the Company has hired a new, full time, Director of Research (non-board role), Michelle Barnard, who brings over 10 years' experience as a Senior Scientist specialising in Oncology Biology at Cancer Research Horizons and in Drug Discovery at the University of Graz prior. The Inaphaea team will also be supported by a specialist technician. These changes are expected to reduce annual costs by approximately £200,000.

Looks good

What ever it is it's cleared and taken

That's nearly 2%

A few trades have ende with 52/62

This was what Miton had left

22195652

And again

Maybe some background buying to show?

Looks like the next move up

Huge seller cleared SAV....should do A EMH

Tiny free float

100% target

This should be moving well past 5p now

Cleared the path for a big rise

Looks like that on the 1 year chart a clear break of 4 5-4.8p signals an important #step .

Financial position

Cash generation from operations was £0.35m (H1 2023: £2.35m) and as at 30 September 2024, the Group's net bank debt, excluding the impact of the IFRS16 lease liability, was £6.66m (H1 2023 £5.57m), representing an increase of £1.81m compared to the end of the previous financial year as cash balances decreased and a new convertible loan note was issued for £0.99m to fund the acquisition of a complementary driver risk solution as reported in the Group's FY2024 results.

The reduced cash generation from operations was again down to Insurance device sales being lower than expected, which compared to Fleet contract wins, turn to positive cashflow in shorter timeframes. We continue to hold more inventory than desired due to Insurance sales volumes and committed material purchases during 2023 when lead times were in excess of twelve months - this represents an opportunity to improve the working capital position as device sales return.

During the period, we agreed revised agreements with both HSBC and Maven and the Group continues to closely monitor its working capital position.

The overall cash outflow for the financial period was £1.04m (H1 2023: £0.25m). Cash on hand was £0.35m (H1 2023: £0.87m) with £0.5m in unused overdraft facility at the period end.

Pity I didn't quite manage all of that